siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
about
Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migrationBacterial-Derived Polymer Poly-γ-Glutamic Acid (γ-PGA)-Based Micro/Nanoparticles as a Delivery System for Antimicrobials and Other Biomedical ApplicationsIntranasal drug delivery of small interfering RNA targeting Beclin1 encapsulated with polyethylenimine (PEI) in mouse brain to achieve HIV attenuation.Self-assembled lipid nanomedicines for siRNA tumor targeting.Confocal microscopy for the analysis of siRNA delivery by polymeric nanoparticles.Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNA.Intranasal delivery of HMGB1 siRNA confers target gene knockdown and robust neuroprotection in the postischemic brain.PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma.Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosisInhibition of Sox2 Expression in the Adult Neural Stem Cell Niche In Vivo by Monocationic-based siRNA DeliveryTargeted delivery of siRNA to activated T cells via transferrin-polyethylenimine (Tf-PEI) as a potential therapy of asthma.Mammalian cell penetration, siRNA transfection, and DNA transfection by supercharged proteins.Therapeutic nanomedicine for brain cancer.Targeted delivery systems for oligonucleotide therapeutics.Polymeric micelles containing reversibly phospholipid-modified anti-survivin siRNA: a promising strategy to overcome drug resistance in cancerCholesterol-Containing Nuclease-Resistant siRNA Accumulates in Tumors in a Carrier-free Mode and Silences MDR1 Gene.Targeted Nanotechnology in Glioblastoma Multiforme.Delivery of therapeutic nucleic acids via transferrin and transferrin receptors: lipoplexes and other carriers.Challenging the future of siRNA therapeutics against cancer: the crucial role of nanotechnology.Therapeutic face of RNAi: in vivo challenges.RNAi therapeutics for brain cancer: current advancements in RNAi delivery strategies.Imaging-guided delivery of RNAi for anticancer treatment.Enhanced antitumor efficacy of cisplatin for treating ovarian cancer in vitro and in vivo via transferrin binding.Combination of sequence-defined oligoaminoamides with transferrin-polycation conjugates for receptor-targeted gene delivery.Inhibition of enhanced green fluorescent protein expression by (dextran-hexamethylenediisocyanate)-g-polyethylenimine/siRNA complexes.Click-modified cyclodextrins as nonviral vectors for neuronal siRNA delivery.The Formation of Nanoparticles between Small Interfering RNA and Amphipathic Cell-Penetrating Peptides.Amphiphilic small peptides for delivery of plasmid DNAs and siRNAs.Polyethylenimine of various molecular weights as adjuvant for transfection mediated by cationic liposomes.
P2860
Q28829561-869CDB76-8164-47AB-A692-AD92B408EFFBQ29248031-47A435AC-18BD-47F1-AEEB-4D63B4E9B2A4Q33687594-29EC02BB-3E4B-4FF8-ABC7-6F045A890F2EQ33907953-6F9C6A0F-B641-4757-BE38-E4A88C1CC0A8Q34097306-B1A81D03-5DDD-4DD7-85A3-44BA7D372B1BQ34640040-54D2493D-2402-4E4D-AA90-94E259CEB0F7Q35876200-8C1C2901-5B57-48D7-A73B-9CD6F0D88D81Q36375834-9705F360-8E1F-47EE-812C-C098CAE5EB60Q36579336-C885756C-2626-4090-ADA2-6AACDD9B1A5FQ36832232-54890CEB-3D40-4044-845F-E632A7F9805BQ36951062-1E0CD42E-22F3-4695-B1F5-E79B1A718687Q37137996-7C22CE38-BDF3-404E-8367-FDEEE904CAE8Q37338427-852E1652-CB19-4962-B8EC-88848A77DF00Q37417572-754DC9D3-9F43-411A-8080-F537489A31BEQ37625926-4C6E608B-79A7-4B5D-86F5-EF6B1E398DA7Q37718210-5CDEA313-D5A1-48ED-8802-F34D5F440900Q37730943-93F0F54D-F802-4223-90E1-9886D95754FAQ38139539-22227C3D-5F07-4D0A-BE76-8E1BA8AC4CF3Q38162098-4D179A6F-D7A7-4121-899D-557FFFF1B15DQ38268541-75F9EEE6-7BBF-4301-B87B-C5933C55E4F9Q38541950-59F6906B-3A8E-4753-B1C3-1B1A98A95EB7Q38710046-8A1638A6-53D7-4F62-9096-A458BECE235DQ38796925-98C59A2E-DE45-4616-9371-7929BBE7D7F6Q38847729-D774EF20-4261-4238-94A5-D0696270F1E0Q39764981-BB930996-BC0F-44AE-BEB3-E29308BE195DQ41973875-4F7299C0-9A1E-474D-81EC-7CBACBCEFCE0Q42314583-5EDFCDCE-4D62-4C31-ADCA-669FB4F70C43Q45873400-4D879055-3A8C-49C1-9599-DBE400887D87Q45883760-12D06352-E8BB-4670-8328-71110F9FB4C4
P2860
siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
siRNA delivery by a transferri ...... egy to mediate gene silencing.
@en
type
label
siRNA delivery by a transferri ...... egy to mediate gene silencing.
@en
prefLabel
siRNA delivery by a transferri ...... egy to mediate gene silencing.
@en
P50
P356
P1476
siRNA delivery by a transferri ...... tegy to mediate gene silencing
@en
P2093
L P de Almeida
P2860
P304
P356
10.1002/JGM.1006
P577
2007-03-01T00:00:00Z